Sarah Cuddy, MD / Vasvi Singh, MD, FACC, FASNC, FSCCT - Transthyretin Cardiac Amyloidosis: Integrating New Paradigms Into Cardiology Practice

About this episode

The episode discusses integrating new paradigms of Transthyretin Cardiac Amyloidosis into cardiology practice.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZCE865. CME/AAPA credit will be available until April 27, 2027. Transthyretin Cardiac Amyloidosis: Integrating New Paradigms Into Cardiology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and The Mended Hearts, Inc.. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc. Disclosure information is available at the beginning of the video presentation.

People in this episode

Guests: Sarah Cuddy, MD, Vasvi Singh, MD, FACC, FASNC, FSCCT

Topics covered

• Transthyretin Cardiac Amyloidosis
• Cardiology Practice
• Patient Care
• Continuing Medical Education

Keywords

• Transthyretin Cardiac Amyloidosis
• Cardiology
• CME
• Patient Care
• Healthcare Professionals

Sponsors

Alnylam Pharmaceuticals, Inc.

Mentioned in this episode

Organizations: PVI, PeerView Institute for Medical Education, The Mended Hearts, Inc.

More episodes of PeerView Internal Medicine CME/CNE/CPE Audio Podcast

• Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings · May 29, 2026 · 55 min
• Anna Chodos, MD, MPH - Getting Ahead of Cognitive Decline—Applying Patient-Centered Strategies to Assess and Reduce Dementia Risk in Primary Care: An AI-Guided Case Simulation Activity · May 29, 2026 · 46 min
• Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice · May 29, 2026 · 38 min
• Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients · May 29, 2026 · 49 min
• Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution · May 29, 2026 · 55 min
• Anita Afzali, MD, MPH, MHCM, FACG, AGAF / Jessica R. Allegretti, MD, MPH, FACG, AGAF / Millie D. Long, MD, MPH - At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition · May 29, 2026 · 1h 11m